Photo of Alessandro Lagana

Alessandro Lagana, PhD Email Alessandro Lagana

    • Position
    • ASSISTANT PROFESSOR | Genetics and Genomic Sciences
    • Language
    • English

Alessandro is an Assistant Professor of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. His main research interests are in the fields of integrative cancer genomics, cancer network biology and precision oncology.

The aim of Alessandro's research is the development and application of computational methods for integrative analysis of multi-omics data to:

  • Investigate the role of coding and non-coding alterations on cancer pathogenesis and progression;
  • Understand the clinical implications of intra-tumor heterogeneity and of the tumor microenvironment;
  • Inform patient risk stratification;
  • Develop personalized therapy selection approaches guided by next-generation sequencing technologies.

Alessandro's current research focuses on Multiple Myeloma, a genetically complex and heterogeneous malignancy of bone marrow plasma cells affecting more than 30,000 patients each year in the United States. The causal drivers of Myeloma pathogenesis are still unclear, and treatment is administered empirically on the basis of recurrence risk rather than genetic events.

Alessandro is leading the development of a precision medicine pipeline that has been successfully applied in a clinical trial to guide treatment of relapsed Multiple Myeloma patients. The goal of precision oncology is to devise optimal treatment strategies tailored to the characteristics of the individual patient’s disease. However, the widespread heterogeneity of cancer patients and drug responses pose a significant challenge in the design of effective personalized treatments. Alessandro's research addresses this extremely important challenge and aims to transform the current paradigm of empirical clinical application. The systematic use of integrative genomics, systems biology approaches, big-data analytics and novel sequencing technologies will enable physicians to provide more precise and effective personalized treatment of cancer.

 

Education

M.Sc. University of Catania, Catania, Italy

Ph.D. University of Catania, Catania, Italy

Language

English